Ondine Biomedical

About:

Ondine Biomedical develops non-antibiotic, anti-infective therapies for a broad spectrum of bacterial, viral, and fungal infections.

Website: http://ondinebio.com

Twitter/X: ondinebio

Top Investors: TELUS Ventures

Description:

Ondine Biomedical Inc. (formerly Ondine Biopharma Corporation) is dedicated to the development of non-antibiotic anti-infective therapies for a broad spectrum of bacterial, viral and fungal infections. The Company is focused on the development and commercialization of its patented light activated technology, Photodisinfection (PDD), for multiple applications. PDD provides antimicrobial efficacy without encouraging the formation and spread of antibiotic resistance. Ondine Biomedical Inc. launched is first PDD product Periowaveâ„¢ in 2006. Periowaveâ„¢ is used as an adjunctive therapy for the treatment of chronic adult periodontitis (gum disease). In June 2009 Ondine sold its Dental Healthcare Business to PDT Inc.